Emerging Diseases News

An FDA advisory committee voted unanimously Thursday in favor of a plan to streamline and simplify COVID-19 vaccine compositions in the United States by replacing initial, primary doses with the bivalent vaccines currently used as boosters.

The EULAR Congress of Rheumatology is set to return this spring as an in-person, onsite-only event, with no live remote options, for the first time since the beginning of the COVID-19 pandemic.

Evusheld is no longer authorized for use to help prevent COVID-19 in the United States “until further notice,” due to a lack of protection against dominant variants, according to new guidance issued by the FDA.

The FDA Antimicrobial Drugs Advisory Committee voted on Wednesday 14-1 in favor of the use of rezafungin for the treatment of candidemia and invasive candidiasis.

The CDC for the first time has estimated how effective the bivalent COVID-19 vaccines have been against the newest dominant omicron subvariant of SARS-CoV-2.

Heart disease remained among the leading causes of death, even amid the COVID-19 pandemic, which may have exacerbated preexisting CVD morbidity-related racial/ethnic disparities, researchers reported.

As the COVID-19 pandemic heads into its 4th year, it is a good time to reflect on strides made for those with mild-to-moderate disease not requiring hospitalization.

What drew me to infectious diseases was the potentially enormous impact it has — not only on individuals but on societies.

WAILEA, Hawaii — A recent increase in invasive group A streptococcal infections in pediatric patients should be monitored and patients treated appropriately, according to a presentation at the Maui Derm meeting.

A survey of U.S. adults who are vaccinated against COVID-19 found that many of them have not received a bivalent booster shot because they either do not know they are eligible for one or are unaware the shots exist.